Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997. (Q34506521)

2 August 2017

title

Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997. (English)

1 reference

2 August 2017

0 references

Uhlenhuth EH

1 reference

2 August 2017

Balter MB

series ordinal

1 reference

2 August 2017

Ban TA

series ordinal

1 reference

2 August 2017

Yang K

series ordinal

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

European Neuropsychopharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

9 Suppl 6

1 reference

2 August 2017

page(s)

S393-8

1 reference

A risk-benefit assessment of pharmacological treatments for panic disorder

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900050-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900050-4

7 January 2021

Abuse of Benzodiazepines: The Problems and the Solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900050-4

7 January 2021

Clinical psychopharmacologic practice. The need for developing a research base.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900050-4

7 January 2021

Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900050-4

7 January 2021

Opioid therapy for chronic nonmalignant pain: clinician's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900050-4

7 January 2021

Pain management and chemical dependency. Evolving perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900050-4

7 January 2021

Symptom checklist syndromes in the general population. Correlations with psychotherapeutic drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900050-4

7 January 2021

Response of panic disorder to fixed doses of alprazolam or imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900050-4

7 January 2021

Clinical variables in pharmacoepidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900050-4

7 January 2021

International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: II. Pharmacotherapy of anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900050-4

7 January 2021

International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900050-4

7 January 2021

International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900050-4

7 January 2021

Abuse liability of flunitrazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900050-4

7 January 2021

10.1016/S0924-977X(99)00050-4

Identifiers

DOI

1 reference

2 August 2017

1 reference